Wiley Matthew T.

CIK 00017597034 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001759703

Recent Transactions

47 trades

Award
Mind Medicine (MindMed) Inc.$MNMD
Stock Option (Right to Buy)
2025-03-17+350,000→ 350,000 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-10-03$0.55/sh−6,272→ 19,011 total
Award
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-17+21,250→ 25,283 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-16$0.69/sh−215→ 4,033 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-15+750→ 4,248 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-09-15−750→ 7,500 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (right to buy)
2024-07-22+1,875→ 1,875 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-17$1.26/sh−244→ 3,498 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-15+750→ 3,742 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-06-15+750→ 8,250 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-06-15−750→ 8,250 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-04-04$2.64/sh−1,008→ 2,992 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-03-15+3,000→ 3,000 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-03-15+3,000→ 9,000 total
Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2023-03-15+12,000→ 12,000 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (Right to Buy)
2023-03-15+36,000→ 36,000 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (Right to Buy)
2022-01-17+85,000→ 85,000 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-06-30$3.51/sh−5,151→ 109,246 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-03-31$6.84/sh−2,573→ 114,397 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-02-22+27,675→ 116,970 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2021-02-22+64,575→ 64,575 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-12-31$1.58/sh−1,541→ 357,181 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-11-30$1.45/sh+7,838→ 358,722 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-09-30$1.66/sh−1,541→ 350,884 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-06-30$1.73/sh−1,541→ 352,425 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-05-06+150,000→ 353,967 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-05-06+150,000→ 150,000 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-04-06$1.40/sh−908→ 203,967 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-04-03+46,394→ 113,445 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-04-03+91,430→ 204,875 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-03-31$2.68/sh−525→ 67,051 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2020-03-09−78,799→ 0 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-03-09+20,896→ 20,896 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-03-09+46,680→ 67,576 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-03-09+59,240→ 59,240 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-03-09+57,086→ 57,086 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Options
2020-03-09−100,000→ 0 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Options
2020-03-09−96,365→ 0 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2020-03-09−35,275→ 78,799 total
Award
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2020-03-02$2.68/sh+1,993→ 114,074 total
Award
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2020-02-24+41,299→ 112,081 total
Award
Foamix Pharmaceuticals Ltd.
Options
2020-02-24+96,365→ 96,365 total
Tax Payment
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2019-12-31$3.28/sh−2,500→ 70,782 total
Award
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2019-11-29$2.16/sh+9,842→ 73,282 total
Purchase
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2019-03-05$3.76/sh+13,440→ 63,440 total
Award
Foamix Pharmaceuticals Ltd.
Options
2018-12-03+100,000→ 100,000 total
Award
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2018-12-03+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O MIND MEDICINE (MINDMED) INC. ONE WORLD TRADE CENTER, SUITE 8500

NEW YORK, NY, 10007

View on SEC.gov